Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Female Sexual Desire: Preliminary research on rats indicates that MT-II, particularly when used with specific hormones, might enhance proactive sexual behaviors, possibly hinting at a future application in elevating female sexual desire [20]
Important Notice This product is intended for laboratory research use only
WHO expands essential medicines list to include GLP-1 agonists and Cystic Fibrosis therapies Key Takeaways: The World Health Organization (WHO) has added GLP-1 receptor agonists, rapid-acting insulin analogues, and innovative cancer therapies to its 2025 Essential Medicines Lists (EMLs), signalling their importance in global diabetes and oncology care
This combinatorial approach aligns with the multi-target philosophy that makes peptide research compelling for mood disorders
US$ 26.52
US$ 25.09
US$ 29.75
US$ 20.84
